BeiGene, Ltd. Depreciation & Amortization 2011-2026 | BGNE

Annual Depreciation & Amortization BeiGene, Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142 M	172 M	87.7 M	66.3 M	46.5 M	31.8 M	18.6 M	10.4 M	4.76 M	1.91 M	1.54 M	1.56 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
172 M	1.54 M	48.7 M

Quarterly Depreciation & Amortization BeiGene, Ltd.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
35.7 M	29.9 M	32.8 M	-	70 M	23.8 M	25.3 M	-	19.2 M	21.3 M	20 M	-	15.2 M	14.5 M	16.6 M	-	33.3 M	21.2 M	9.63 M	-	24 M	15.6 M	7.75 M	-	11.1 M	7.11 M	3.42 M	-	7.02 M	4.58 M	2.24 M	-	2.7 M	1.4 M	864 K	-	1.44 M	492 K	439 K	-	402 K	373 K	352 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
70 M	352 K	14.5 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aligos Therapeutics ALGS	930 K	$ 8.65	8.19 %	$ 85.5 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Esperion Therapeutics ESPR	105 K	$ 2.14	-1.38 %	$ 445 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 20.47	0.49 %	$ 957 M	USA
GT Biopharma GTBP	4 K	$ 0.36	-2.82 %	$ 1.98 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Halozyme Therapeutics HALO	11.4 M	$ 67.06	-1.12 %	$ 8.04 B	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 28.69	-0.69 %	$ 1.65 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.41	0.71 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.96	1.37 %	$ 4.87 M	Israel
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.16	1.84 %	$ 445 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.01	-0.85 %	$ 3.05 B	USA
ImmuCell Corporation ICCC	2.78 M	$ 7.12	1.14 %	$ 64.3 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 32.24	-	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.48	-0.67 %	$ 394 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
Incyte Corporation INCY	93.3 M	$ 94.86	-1.26 %	$ 18.5 B	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.61	2.35 %	$ 16.4 M	USA